Covalently linked polypeptide cell modulators such as interferon

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 852, 424 854, 424 855, 424 856, 424 857, 424 858, 530351, 530395, 530405, 530409, 5303911, 5303917, 5303919, 53038823, 5303892, 514 2, 514 8, 514 12, 514 21, 930142, 930143, A61K 3766, A61K 3944, C07K 1526, C07K 1702

Patent

active

051147114

ABSTRACT:
Described is a new class of polypeptide cell modulators characterized by being composed of two covalently linked cell modulators in a linear polypeptide sequence. Such dual function polypeptides have new and particularly useful activities when the component polypeptide cell modulators are interferons, lymphokines or cytotoxins which act through different and specific cell receptors to initiate complementary biological activities.

REFERENCES:
patent: Re32637 (1988-04-01), Ishida
patent: 4468382 (1984-08-01), Bacha et al.
Rudinger in J. A. Parsons ed Peptide Hormones Univ. Park Press Baltimore, Jun. 1976 pp. 1-7.
CA 106(9):159 abstract #62196j.
Shepard et al (1984) Nature 294:563-565.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Covalently linked polypeptide cell modulators such as interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Covalently linked polypeptide cell modulators such as interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently linked polypeptide cell modulators such as interferon will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2416395

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.